Principal Investigator


Wilbert B. van den Hout

Dr. Wilbert van den Hout works as a senior researcher in the area of health technology assessment. The main focus of his work is on economic evaluations, alongside clinical trials or using mathematical models.

Doctor Wilbert B. van den Hout
Wilbert B. van den Hout
Location: LUMC, Netherlands
See ORCID Profile
Personal website

Dr. Wilbert van den Hout has conducted a multitude of economic evaluations, based on patient-related clinical trials, or using mathematical models. He works together with several researchers to predict the economic impact of their new therapies.

Dr. Van den Hout carries out studies on the methodology of cost-effectiveness research, ranging from pragmatic design, measurement, and the valuation of health care use, productivity, and quality of life. His research also focuses on the effect of disease modelling, the net-benefit analysis of developing a therapy, as well as the value of health for society as a whole.

Dr. Van den Hout is principal investigator within reNEW’s PREPARE theme at its Leiden node. He works as a senior researcher in health technology assessment at the Department of Biomedical Data Sciences at the Leiden University Medical Center (LUMC).

Dr. Van den Hout started his career as an econometrist and now uses his mathematical background to improve the implementation of new health care interventions as health economist. He has supervised 10 PhD students and published over 130 articles on the topic of health technology assessment.


reNEW researchers have a strong track record of scientific excellence in stem cell biology

They have performed pioneering work in stem cell research spanning different tissue and cell types, different technological advances and different stages of applied research. This provides an unprecedented international opportunity to utilise the combined wealth of knowledge, complementary skills sets and clinical experience across reNEW to push stem cell discoveries toward translational outcomes.